Zeteo Tech is a venture-backed biodefense and medical device company revolutionizing the field of biological mass spectrometry technology [8]. Based in Sykesville, Maryland, the company specializes in developing advanced fieldable mass spectrometers for identifying airborne microbes, proteins, and lipids, with crucial applications in infectious disease screening and biothreat detection [1].
- Tom McCreery as VP, Innovation/COO
- Jerry Carlisle as CFO
- Mike McLoughlin as VP, Research
- Advanced biodefense and medical device development
- Mass spectrometry solutions for biothreat detection
- Innovative breath-based diagnostic technologies (BreathBiomics™)
- Comprehensive critical infrastructure protection systems
- Receipt of the prestigious 2020 Tibbetts Award [8]
- Multiple patents in mass spectrometry technology [4]
- A $1.87M contract from DHS Science & Technology Directorate [4]
- DHS S&T Phase III SBIR contract with potential value of $5.86M (2023)
- NIH/NIAID Direct Phase II SBIR grant of $1.9M for respiratory diagnostics
- NOAA SBIR Phase I grant of $175K for algal bloom detection
- DHS S&T $6.5M contract for biothreat detection technology
- Adherence to 42 CFR Part 50 Part F and 45 CFR Part 94 regulations
- Compliance with Federal Acquisition Regulation FAR 52.203-16
- Implementation of government contract-required security protocols
The company continues to expand its technological capabilities and intellectual property portfolio while maintaining strong relationships with federal agencies. Their strategic developments are supported by an advisory board that includes former senior DoD and federal science officials [5], positioning them for continued growth in the biodefense and public health sectors.